sb 203580 has been researched along with az 11645373 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (az 11645373) | Trials (az 11645373) | Recent Studies (post-2010) (az 11645373) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 22 | 0 | 16 |
Protein | Taxonomy | sb 203580 (IC50) | az 11645373 (IC50) |
---|---|---|---|
P2X purinoceptor 7 | Homo sapiens (human) | 0.031 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldwin, SA; Caseley, EA; Fishwick, CW; Jiang, LH; Muench, SP; Simmons, K | 1 |
1 other study(ies) available for sb 203580 and az 11645373
Article | Year |
---|---|
Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Binding Sites; Humans; Molecular Docking Simulation; Molecular Sequence Data; Protein Structure, Tertiary; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Sequence Alignment | 2015 |